International Journal of Molecular Sciences · 2022 · 19 citations · 29 references
Life SciencesGeneticsHematologyCytogeneticsGenomicsMolecular OncologyCancer CytogeneticsCancer GenomicsClinical CytogeneticsMolecular CytogeneticsPediatric Cancer GeneticsPediatric LeukemiasDiagnostic StrategyDiagnostic Strategy DevelopmentGenomic RearrangementsLeukemia ClassificationLeukemia CytogeneticsLeukemia DiagnosticsMolecular Cytogenetic DiagnosisUnbalanced Rearrangements
Ph-like subtypes with CRLF2 abnormalities are frequent among Hispano–Latino children with pre-B ALL. Therefore, there is solid ground to suggest that this subtype is frequent in Mexican patients. The genomic complexity of Ph-like subtype constitutes a challenge for diagnosis, as it requires diverse genomic methodologies that are not widely available in diagnostic centers in Mexico. Here, we propose a diagnostic strategy for Ph-like ALL in accordance with our local capacity. Pre-B ALL patients without recurrent gene fusions (104) were classified using a gene-expression profile based on Ph-like signature genes analyzed by qRT-PCR. The expressions of the CRLF2 transcript and protein were determined by qRT-PCR and flow cytometry. The P2RY8::CRLF2, IGH::CRLF2, ABL1/2 rearrangements, and Ik6 isoform were screened using RT-PCR and FISH. Surrogate markers of Jak2-Stat5/Abl/Ras pathways were analyzed by phosphoflow. Mutations in relevant kinases/transcription factors genes in Ph-like were assessed by target-specific NGS. A total of 40 patients (38.5%) were classified as Ph-like; of these, 36 had abnormalities associated with Jak2-Stat5 and 4 had Abl. The rearrangements IGH::CRLF2,P2RY8::CRLF2, and iAMP21 were particularly frequent. We propose a strategy for the detection of Ph-like patients, by analyzing the overexpression/genetic lesions of CRLF2, the Abl phosphorylation of surrogate markers confirmed by gene rearrangements, and Sanger sequencing.
29
Sue Richards, Nazneen Aziz, Sherri J. Bale et al. · Genetics in Medicine · 2015 · 32.2K citations · Full text
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
Charles G. Mullighan, Xiaoping Su, Jinghui Zhang et al. · New England Journal of Medicine · 2009 · 1.4K citations · Full text
Life Sciences, Genetics, Hematology +15
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
Kathryn G. Roberts, Yongjin Li, Debbie Payne-Turner et al. · New England Journal of Medicine · 2014 · 1.4K citations · Full text
Life Sciences, Genetics, Oncology +17